Product Information
AMETHYST 90-20 MCG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.1504 per EA under NDC 00480347224. Its NADAC has been published 174 times since Apr 26, 2023.
FDA first approved this application on Jun 6, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20; 90 ug/1; ug/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480347224
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ETHINYL ESTRADIOL; LEVONORGESTRELApproval Type
Generic (ANDA)
FDA Application
ANDA079218FDA Approved
6/6/2011
TE Code
AB
On Market Since
3/1/2023
Pharmacological Classes
Price Statistics
The NADAC for AMETHYST 90-20 MCG TABLET has been published 174 times since Apr 26, 2023, and over the history we have for it it has risen 4.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1504 per EA |
|---|---|
| All-time high | $1.3471 (Jul 12, 2023) |
| All-time low | $0.7929 (Nov 20, 2024) |
| 52-week high | $1.2766 |
| 52-week low | $1.1504 |
| Median price | $1.1928 |
| Average price | $1.1380 |
| Largest weekly change | -28.9% (Nov 20, 2024) |
| Weeks tracked | 174 |
| Tracking since | Apr 26, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMETHYST 90-20 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AMETHYST 90-20 MCG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $1.1504 per EA (NDC 00480347224), effective Aug 19, 2026.
How has the price of AMETHYST 90-20 MCG TABLET changed over time?
Over the history we have for it, the NADAC for AMETHYST 90-20 MCG TABLET has risen 4.4%. It has been tracked across 174 weekly CMS publications since Apr 26, 2023.
What are the highest and lowest recorded NADAC prices for AMETHYST 90-20 MCG TABLET?
Since Apr 26, 2023, the NADAC for AMETHYST 90-20 MCG TABLET has ranged from a low of $0.7929 (Nov 20, 2024) to a high of $1.3471 (Jul 12, 2023), with a median of $1.1928 per EA.
Are there cheaper alternatives to AMETHYST 90-20 MCG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMETHYST 90-20 MCG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures AMETHYST 90-20 MCG TABLET?
AMETHYST 90-20 MCG TABLET (NDC 00480347224) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.